L. Mastroianni et al., A COMPARISON OF 10-PERCENT PENTASTARCH AND 5-PERCENT ALBUMIN IN PATIENTS UNDERGOING OPEN-HEART-SURGERY, Journal of clinical pharmacology, 34(1), 1994, pp. 34-40
Colloids are useful in cardiac surgery to increase preload and improve
cardiac output without the risks associated with blood transfusions.
Pentastarch is a new low-molecular weight hydroxyethyl starch compound
under investigation for this purpose. The authors compared, in a rand
omized fashion, 17 patients who received pentastarch and 17 patients w
ho received albumin for volume expansion after open-heart surgery. Dur
ing the 24-hour study period there was no significant difference betwe
en the two groups with respect to systemic blood pressure, mean arteri
al pressure, cardiac index, right atrial pressure, and pulmonary capil
lary wedge pressure, with the exception of a higher mean arterial pres
sure and systolic blood pressure at 4 hours in the albumin group and h
igher heart rate at 12 hours in the pentastarch group. In addition, po
stoperative prothrombin time, partial thromboplastin time, fibrinogen,
platelets, and factor VIII levels were not significantly different be
tween the two groups, There were no complications attributed to colloi
d administration. The hemodynamic parameters were further evaluated in
a subset of 6 pentastarch and 9 albumin patients who received the fir
st 500 mL of colloid in a similar time frame and under similar clinica
l conditions. The patients who received pentastarch showed a significa
ntly greater increase in cardiac index than did the patients who recei
ved albumin. No significant change in other parameters were noted betw
een the two groups. The authors conclude that pentastarch is as safe a
s albumin and may be a more effective volume expander than albumin whe
n used in open-heart surgery patients.